Radhika Tripuraneni Net Worth

Radhika Tripuraneni biography

Dr. Radhika Tripuraneni M.D. serves as Chief Development Officer of the Company. Prior to that, she was our Vice President, Medical Affairs and Development Operations. Prior to joining Prothena in 2018, Dr. Tripuraneni was Vice President, Medical Affairs and Chief of Staff to the Chief Medical Officer of MyoKardia Inc. (a biotechnology company), positions she held from 2017 to 2018. From 2012 to 2017, she was Vice President, Medical Affairs at Synageva BioPharma Corp. (a biopharmaceutical company) and then Alexion Pharmaceuticals (a pharmaceutical company), which acquired Synageva in 2015. Dr. Tripuraneni held various medical director positions at Gilead Sciences, Inc. and Genzyme Corporation (both biopharmaceutical companies) from 2007 to 2012, and prior to that worked at Summer Street Research Partners (an equity research firm). She earned her BAs in business and liberal arts and her MD from the University of Missouri, and her Master in Public Health from Harvard University. Dr. Tripuraneni did her clinical training in general surgery at Harvard - Beth Israel Deaconess Medical Center.

What is the salary of Radhika Tripuraneni?

As the Chief Development Officer of Prothena plc, the total compensation of Radhika Tripuraneni at Prothena plc is $1,055,690. There are 5 executives at Prothena plc getting paid more, with Wagner Zago having the highest compensation of $3,341,640.